The inverse relationship between higher levels of BRAF V600E and ANXA7 can be seen when comparing these cell lines, indicating a tumor suppressive role in thyroid cancer that is inhibited with the aggressive and oncogenic BRAF V600E mutation. Here, BRAF is linked to neoplasm.